OTHER NEWS
Concept Development Workshops supported by Below the Belt Pedalthon In November 2014 four concept development workshops held over two days took place in Sydney. It was the first time ANZUP had been able to bring these workshops together. The funding to allow this to happen came directly from the inaugural Below the Belt Challenge.
Participants from around Australia and New Zealand in Sydney for the inaugural two day Concept Development Workshop
In 2015, our corporate and community partners will join us on Tuesday 1 September at Sydney Motorsport Park, Eastern Creek to do it all again. We are looking forward to welcoming more than 40 teams whose riding and fundraising efforts will once again provide much needed untied funding to ANZUP. Race Founder Simon Clarke said, “I am delighted to be involved in the Pedalthon again and am so proud of the $225,000 we were able to donate to ANZUP last year. I encourage all ANZUP members to support the ride by either riding in a team or sponsoring the ANZUP/CTC teams”. Simon has been seconded to New York for a year but is still actively involved in pursuing sponsors and additional teams. We are very grateful to Simon and the Clarke and Jones families for their financial support and the time they are committing to the ride.
Craig Gedye presenting is concept “Single arm phase I/II biomarker enriched trial of safety, tolerability and activity of metronomic vinorelbine (Navelbine®) in patients with pre-treated metastatic clear cell renal cell carcinoma
The race is unique in style as it is focussed on the corporate sector, is on a closed circuit and is all over in one day. Teams pay a registration fee of $2,000, and each rider is asked to raise at least $500. Last year, some teams were supported by matched giving in addition to their individual fundraising; please keep that in mind if you have any interested family members or any friends in Sydney based corporates. Further details about the Pedalthon can be found at www.belowthebelt.org.au. 20 | ANZUP UPdate
CTC’s Karen Bracken (Sydney), Trial Nurse Co-ordinator Kath Schubach (Melbourne) and Urological Registrar Steve McCombie (Perth)